E
Sell
3/10/2025Upgraded
ZyVersa Therapeutics, Inc. (ZVSA) was upgraded to E+ from E on 3/10/2025 due to an increase in the volatility index.
E
Sell
1/6/2025Downgrade
ZyVersa Therapeutics, Inc. (ZVSA) was downgraded to E from E+ on 1/6/2025 due to a large decline in the solvency index and volatility index. The quick ratio declined from 0.01 to 0.01.
E
Sell
4/10/2023Upgraded
ZyVersa Therapeutics, Inc. (ZVSA) was upgraded to E+ from E on 4/10/2023 due to a significant increase in the solvency index and growth index. The quick ratio increased from 0.04 to 0.72, earnings per share increased from -$0.5535 to $0.2528, and EBIT increased 10.6% from -$3.4M to -$3.04M.
E
Sell
3/16/2023Downgrade
ZyVersa Therapeutics, Inc. (ZVSA) was downgraded to E from E+ on 3/16/2023 due to a noticeable decline in the total return index and volatility index.
E
Sell
12/27/2022None
ZyVersa Therapeutics, Inc. (ZVSA) was downgraded to E+ from U on 12/27/2022.
